Human epidermal growth factor receptor 2 (HER-2), a tyrosine kinase receptor assigned to the family of epidermal growth factor receptor (EGFR), is a crucial gastric cancer therapeutic target encoded by the c-erbB2 proto-oncogene located on chromosome 17q212. Here, ERBB2 is linked to gastric cancer.